Stiripentol vs add‐on placeboGastrointestinal adverse events · people with drug‐resistant focal epilepsy1 finding from 1 reviewStiripentol add‐on therapy for drug‐resistant focal epilepsy 2022 · Cochrane Headline outcomes onlyno estimate extracted1 study · 32 participantsGRADE not reported